Correction: Detection of Colorectal Cancer (CRC) by Urinary Volatile Organic Compound Analysis

Colorectal cancer (CRC) is a leading cause of cancer related death in Europe and the USA. There is no universally accepted effective non-invasive screening test for CRC. Guaiac based faecal occult blood (gFOB) testing has largely been superseded by Faecal Immunochemical testing (FIT), but sensitivity still remains poor. The uptake of population based FOBt testing in the UK is also low at around 50%. The detection of volatile organic compounds (VOCs) signature(s) for many cancer subtypes is receiving increasing interest using a variety of gas phase analytical instruments. One such example is FAIMS (Field Asymmetric Ion Mobility Spectrometer). FAIMS is able to identify Inflammatory Bowel disease (IBD) patients by analysing shifts in VOCs patterns in both urine and faeces. This study extends this concept to determine whether CRC patients can be identified through non-invasive analysis of urine, using FAIMS. 133 patients were recruited; 83 CRC patients and 50 healthy controls. Urine was collected at the time of CRC diagnosis and headspace analysis undertaken using a FAIMS instrument (Owlstone, Lonestar, UK). Data was processed using Fisher Discriminant Analysis (FDA) after feature extraction from the raw data. FAIMS analyses demonstrated that the VOC profiles of CRC patients were tightly clustered and could be distinguished from healthy controls. Sensitivity and specificity for CRC detection with FAIMS were 88% and 60% respectively. This study suggests that VOC signatures emanating from urine can be detected in patients with CRC using ion mobility spectroscopy technology (FAIMS) with potential as a novel screening tool. Citation: Arasaradnam RP, McFarlane MJ, Ryan-Fisher C, Westenbrink E, Hodges P, et al. (2014) Detection of Colorectal Cancer (CRC) by Urinary Volatile Organic Compound Analysis. PLoS ONE 9(9): e108750. doi:10.1371/journal.pone.0108750 Editor: Keping Xie, The University of Texas MD Anderson Cancer Center, United States of America Received June 13, 2014; Accepted August 25, 2014; Published September 30, 2014 Copyright: 2014 Arasaradnam et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are included within the paper. Funding: The work was supported by Bardhan Research and Education Charity (BRET) charity, Warwickshire Private Hospital charity, Eveson trust provided funding for materials. BRET was established by Professor Bardhan but he had no input into the funding decision made by the grant awarding committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist. * Email: r.arasaradnam@warwick.ac.uk

[1]  J. Covington,et al.  Differentiating Coeliac Disease from Irritable Bowel Syndrome by Urinary Volatile Organic Compound Analysis – A Pilot Study , 2014, PloS one.

[2]  Catherine Bailey,et al.  Detection of Colorectal Cancer (CRC) by Urinary Volatile Organic Compound Analysis , 2014, PloS one.

[3]  C Harmston,et al.  Review article: next generation diagnostic modalities in gastroenterology – gas phase volatile compound biomarker detection , 2014, Alimentary pharmacology & therapeutics.

[4]  C. Mulder,et al.  Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study , 2014, International journal of cancer.

[5]  H. Allawi,et al.  Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  Ruth Harbord,et al.  Application of a Novel Tool for Diagnosing Bile Acid Diarrhoea , 2013, Sensors.

[7]  H. Brenner,et al.  Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. , 2013, European journal of cancer.

[8]  Norman Ratcliffe,et al.  A Pilot Study Combining a GC-Sensor Device with a Statistical Model for the Identification of Bladder Cancer from Urine Headspace , 2013, PloS one.

[9]  James A. Covington,et al.  A Novel Tool for Noninvasive Diagnosis and Tracking of Patients with Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.

[10]  L. Trizio,et al.  Exhaled volatile organic compounds identify patients with colorectal cancer , 2013, The British journal of surgery.

[11]  T. Imperiale Noninvasive Screening Tests for Colorectal Cancer , 2012, Digestive Diseases.

[12]  James A. Covington,et al.  The Detection of Patients at Risk of Gastrointestinal Toxicity during Pelvic Radiotherapy by Electronic Nose and FAIMS: A Pilot Study , 2012, Sensors.

[13]  J. Covington,et al.  Evaluation of gut bacterial populations using an electronic e-nose and field asymmetric ion mobility spectrometry: further insights into ‘fermentonomics’ , 2012, Journal of medical engineering & technology.

[14]  Giuseppe Lippi,et al.  Article in press-uncorrected proof Mini Review Canine olfactory detection of cancer versus laboratory testing : myth or opportunity ? , 2012 .

[15]  C. Silva,et al.  Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry , 2011, British Journal of Cancer.

[16]  E. Pilozzi,et al.  Alteration of Local Microflora and &agr;-defensins Hyper-production in Colonic Adenoma Mucosa , 2011, Journal of clinical gastroenterology.

[17]  S. Moss,et al.  Edinburgh Research Explorer Performance measures in three rounds of the English bowel cancer screening pilot , 2022 .

[18]  J. Covington,et al.  Electronic nose versus canine nose: clash of the titans , 2011, Gut.

[19]  Yoshihiro Kakeji,et al.  Colorectal cancer screening with odour material by canine scent detection , 2011, Gut.

[20]  J A Covington,et al.  Insights into ‘fermentonomics’: evaluation of volatile organic compounds (VOCs) in human disease using an electronic ‘e-nose’ , 2011, Journal of medical engineering & technology.

[21]  V. Preedy,et al.  Bioactive Foods and Extracts : Cancer Treatment and Prevention , 2010 .

[22]  Sven Rahmann,et al.  Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry , 2010 .

[23]  H. Haick,et al.  Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors , 2010, British Journal of Cancer.

[24]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 2008. , 2010, European journal of cancer.

[25]  K D Bardhan,et al.  Colonic fermentation--more than meets the nose. , 2009, Medical hypotheses.

[26]  Giorgio Pennazza,et al.  A preliminary study on the possibility to diagnose urinary tract cancers by an electronic nose , 2008 .

[27]  Bogusław Buszewski,et al.  Human exhaled air analytics: biomarkers of diseases. , 2007, Biomedical chromatography : BMC.

[28]  Ben Lacy Costello,et al.  The FASEB Journal • Research Communication Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease , 2022 .

[29]  M. Phillips,et al.  Volatile Markers of Breast Cancer in the Breath , 2003, The breast journal.

[30]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.